Acta Materia Medica Call for Papers

Platinum open access journal – no APCs during 2023

Fast publication times

The Co-Editors-in-Chief of Acta Materia Medica (AMM), Hongxi Xu, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China and Wenyi Wei, Harvard Medical School, Boston, MA, USA invite you to submit an article to the journal.

Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management.

The journal welcomes the following article types:

  • Research articles
  • Review articles
  • Databases
  • Mini reviews
  • Commentaries
  • Editorials
  • Short communications
  • Case report articles
  • Study protocols.

Benefits of choosing AMM for your research

  • AMM is a platinum open access journal. This means that permanent and free access to published scientific works for readers from the ScienceOpen
  • No Author submission or article processing charges during 2023.
  • Fast peer review.
  • Fast publication online after article acceptance.
  • Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • Authors retain the copyright to their article.
  • Professional/global marketing/promotion of your articles. Articles are:
    • Sent to clinicians and researchers through email alerts;
    • Promoted to the Journal followers on Twitter and Facebook;
    • Distributed to news outlets through press releases.

Submissions: Articles can be submitted to Acta Materia Medica using ScholarOne, the online submission and peer review system. Registration and access are available at There are no author submission or article processing fees.

Editorial Board:

For more information about the journal, including article submission guidelines and how to register for free content-alerting services, please visit:

Articles of interest include:

PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives

Oral delivery of glutathione: antioxidant function, barriers and strategies

Small-molecule fluorescence-based probes for aging diagnosis

Research progress in 3D-printed medicinal tablets

Structure prediction of the entire proteome of monkeypox variants

Advances in therapeutic agents targeting quiescent cancer cells

Ligands for oral delivery of peptides across the blood-brain-barrier

Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells

Discovery and characterization of naturally occurring chalcones as potent inhibitors of bile salt hydrolases

The ‘New (Nu)-clear’ evidence of the tumor-driving role of PI3K

Acta Materia Medica is indexed in the OCLC, WorldCat, Primo Central (Ex Libris), Sherpa Romeo, CNKI Scholar (Chinese National Knowledge Infrastructure), and Summon Databases.

Follow AMM

Twitter @AMM_journal